Found 10 matching trials
Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease EARLY_PHASE1 this is an investigator-initiated trial aimed at evaluating the efficacy an...
Show More Location
Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000
Learn More & Join Trial
Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma NA This is a single-arm, open-label, exploratory clinical study to evaluate th...
Show More Location
Renji Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma EARLY_PHASE1 The purpose of this study is to infuse BCMA CAR-NK cells(Umbilical \& Cord ...
Show More Location
Department of Hematology, Xinqiao Hospital
Learn More & Join Trial
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases EARLY_PHASE1 A single arm, open-label pilot study is designed to determine the safety an...
Show More Location
The Children's Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL EARLY_PHASE1 This study is a single-arm, open-label, dose-escalation trial to explore th...
Show More Location
Shanghai Changzheng Hospital
Learn More & Join Trial
FT576 in Subjects With Multiple Myeloma PHASE1 This is a Phase I dose-finding study of FT576 as monotherapy and in combina...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases EARLY_PHASE1 Evaluating the efficacy and safety of anti-CD19/BCMA CAR-NK Cells in Paedia...
Show More Location
Children's Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma PHASE1 Immunotherapy has shown promise in the treatment of hematological malignanc...
Show More Location
Shariati Hospital
Learn More & Join Trial
An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy EARLY_PHASE1 A single arm, open-label pilot study is designed to evaluate the safety and...
Show More Location
Jieyang People's Hospital
Learn More & Join Trial
Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM PHASE1 The purpose of this study is to infuse BCMA CAR-NK 92 cells to the patients...
Show More Location
Department of Hematology, Wuxi People's Hospital, Nanjing Medical University
Learn More & Join Trial